Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Translational Stroke Research|December 5, 2019
A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental StrokeJea-Young Lee, Vanessa Castelli, Brooke Bonsack, et al.
Current Eye Research|March 24, 2021
Repeatability of Macular and Optic Nerve Head Measurements by Optical Coherence Tomography Angiography in Healthy ChildrenPilar Pérez-García, Laura Morales-Fernández, José Ignacio Fernández-Vigo, et al.
Scientific Reports|May 2, 2018
Parallel evolution of vgsc mutations at domains IS6, IIS6 and IIIS6 in pyrethroid resistant Aedes aegypti from MexicoKarla Saavedra-Rodriguez, Farah Vera Maloof, Corey L Campbell, et al.
Pharmaceutics|February 11, 2021
Novel Use of PLGA Microspheres to Create an Animal Model of Glaucoma with Progressive Neuroretinal DegenerationDavid Garcia-Herranz, Maria Jesus Rodrigo, Manuel Subias, et al.
Eye (London, England)|April 13, 2018
Diagnostic capacity of SD-OCT segmented ganglion cell complex versus retinal nerve fiber layer analysis for congenital glaucomaLaura Morales-Fernandez, Maria Jimenez-Santos, Jose M Martinez-de-la-Casa, et al.
Eye and Vision (London, England)|April 1, 2022
Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye dropsJose Maria Martinez-de-la-Casa, Carlos Oribio-Quinto, Almudena Milans-Del-Bosch, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 31, 2022
One-Year Changes in Optic Nerve Head Parameters in Recovered COVID-19 PatientsBarbara Burgos-Blasco, Noemi Güemes-Villahoz, Beatriz Vidal-Villegas, et al.
Drug Delivery|July 29, 2022
Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheresAlba Aragón-Navas, María J Rodrigo, David Garcia-Herranz, et al.
The British Journal of Ophthalmology|May 9, 2025
Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropineNoemi Guemes-Villahoz, Paula Talavero González, Paloma Porras-Ángel, et al.
Ophthalmology. Glaucoma|September 5, 2025
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma:5-Year Safety Results from a Randomized, Multicenter StudyJoseph F Panarelli, Marlene R Moster, Julian Garcia-Feijoo, et al.
Pageof 14